Project Grant R01DA062408
Award Date 9/30/25
Completion Date 5/31/30
Dollars Obligated $739K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Roxbury, MA 02118, USA
Similar Awards
- This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $844,475 to the University of Alabama at Birmingham (UAB) to test a bundled intervention aimed at increasing treatment uptake for patients with opioid use disorder (OUD) and nonfatal opioid overdoses after emergency department (ED) discharge. The proposed intervention combines telehealth, peer support, buprenorphine prescribing, and linkage to...
- This federal Project Grant award of $144,252 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will fund a research program led by Dr. Carreiro at the University of Massachusetts Medical School (UMMS). The key objectives are to: Develop a novel wearable sensing system called "MINDER" to continuously monitor physiological parameters and use machine learning to accurately identify adherence to buprenorphine treatment for opioid use...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $201,960 Project Grant to the University of Utah under the federal Drug Use and Addiction Research Programs (CFDA 93.279). The funding supports a research study titled "Building Evidence for Effective Extended-Release Buprenorphine Treatment for Opioid Use Disorder." The goal is to generate evidence on the optimal use of extended-release buprenorphine, a newer medication-based...
- This federal Cooperative Agreement award of $680,100 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is intended to investigate the use of a combined transcranial direct current stimulation (tDCS) and cognitive training intervention as an adjunct treatment for individuals with opioid use disorder (OUD) who are receiving buprenorphine maintenance treatment. The key products and services to be delivered under this award include:...
- This $147,486 federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will support a mixed-methods study examining the predictors and outcomes of methadone and buprenorphine receipt during incarceration. The study will analyze a longitudinal database on health service use and outcomes among 4,558 incarcerated individuals who received these medications from 2016-2023 at a unified jail and prison system in the Northeast....
- This Cooperative Agreement award from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, is for a project titled "Strengthening Buprenorphine Treatment for Individuals in Carceral Settings (STAND): A Hybrid Implementation-Effectiveness Trial of Long-Acting Injectable versus Sublingual Buprenorphine." The project aims to conduct a large randomized controlled trial comparing the effectiveness of long-acting injectable buprenorphine versus sublingual...
- This Project Grant award of $398,137 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is for developing high-precision epigenetic therapeutics to address the growing opioid use disorder (OUD) epidemic in the United States. The award will enable Boston Interactome LLC to apply a novel approach targeting protein-protein interactions of the neuronal G9A complex, a key regulator of DFosB expression under chronic opioid exposure....
- This federal Project Grant award of $4,665,000 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant will fund the development and testing of a novel, nurse-led "Community-Based Opioid Treatment (CBOT)" model to deliver opioid use disorder treatment and HIV prevention and care services directly in the community setting. The goal is to improve long-term...
- The National Institute on Drug Abuse (NIDA) has awarded a $731,275 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Massachusetts Medical School (UMMS) to support the "Supporting Treatment Access and Recovery in Re-entry (STAR-R)" study. The 5-year study will evaluate the effectiveness of the "Maintaining Independence and Sobriety through Systems Integration, Outreach, and Networking-Criminal Justice Version (MISSION-CJ)"...
- This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $187,023 to Baystate Medical Center, Inc. in Massachusetts. The purpose is to conduct a mixed-methods study to determine the impact of the state's Behavioral Health Supports for Justice-Involved Individuals (BH-JI) program on healthcare utilization, costs, and overdose outcomes for individuals with opioid use disorder (OUD) upon release from...